How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.
Kahn
Jonathan
J
Center for Bioethics, University of Minnesota, USA.
D001741:Black or African American; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003132:Commerce / Q000331:legislation & jurisprudence*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004338:Drug Combinations; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D006333:Heart Failure / Q000188:drug therapy / Q000208:ethnology / Q000401:mortality; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D012189:Retrospective Studies; D014481:United States
D002317:Cardiovascular Agents; D004338:Drug Combinations; C431665:isosorbide-hydralazine combination; D006830:Hydralazine; D007548:Isosorbide Dinitrate